Global Update on the Cell & Gene Therapy Regulatory Landscape

CELL AND GENE THERAPY INSIGHTS

Global Update on the Cell & Gene Therapy Regulatory Landscape

June 2018
Global Update on the Cell & Gene Therapy Regulatory Landscape
Download PDF

Editorial

New Gene Therapy CMC Guidance from the FDA – A Breakthrough in Regulation or Something More Generic?

New Gene Therapy CMC Guidance from the FDA – A Breakthrough in Regulation or Something More Generic?

Anthony H Davies
14 August 2018
Read

Expert Insight

Accelerated Access of Advanced Regenerative Therapies: an Industry Perspective

Accelerated Access of Advanced Regenerative Therapies: an Industry Perspective

Yaron Ramati
6 August 2018
Read
The Regulatory Environment for Cell Therapies in Australia – an Opportunity to Expedite Clinical Development

The Regulatory Environment for Cell Therapies in Australia – an Opportunity to Expedite Clinical Development

Simon Bishop, Simone Flight, Natalie Thomas
30 July 2018
Read
Breakthrough Therapy Designation & Regenerative Medicine Advanced Therapy Designation Programs in Cellular & Gene Therapies

Breakthrough Therapy Designation & Regenerative Medicine Advanced Therapy Designation Programs in Cellular & Gene Therapies

Xiaofei Wang, Wilson W Bryan, Lei Xu
30 July 2018
Read
Proposed Solutions to Further Improve the Regulatory Landscape for ATMPs in Europe

Proposed Solutions to Further Improve the Regulatory Landscape for ATMPs in Europe

A Hubert, J Barry, C Vieira et al.
17 July 2018
Read
Experiences from Japan – SAKIGAKE Designation System for Regenerative Medical Products

Experiences from Japan – SAKIGAKE Designation System for Regenerative Medical Products

Y Maruyama, M Kasai, K Oyama et al.
17 July 2018
Read